@wombat777
This makes sense. Also as I understand, the purpose of a US-based phase 2/3 trial is for regulatory/FDA approval, as much as it is about collecting more data on efficacy.
I believe the concern over IND really has to do with shareholders' expectation of a transaction. The buyout objective was pushed from ~1 year to ~2/3 years as a result of cardio-protection discovery. Further delays could make some of the shareholders unhappy (regardless of increasing RAC's buyout value).
- Forums
- ASX - By Stock
- RAC
- Ann: Race investor briefing invitation
Ann: Race investor briefing invitation, page-17
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.68 |
Change
0.020(1.20%) |
Mkt cap ! $286.2M |
Open | High | Low | Value | Volume |
$1.68 | $1.68 | $1.61 | $177.8K | 108.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1100 | $1.64 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.68 | 4999 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 31221 | 1.625 |
1 | 5000 | 1.620 |
1 | 30000 | 1.615 |
2 | 16249 | 1.610 |
4 | 26875 | 1.600 |
Price($) | Vol. | No. |
---|---|---|
1.680 | 4999 | 1 |
1.720 | 17729 | 2 |
1.730 | 25792 | 1 |
1.750 | 508 | 1 |
1.780 | 4483 | 1 |
Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |